Clinical efficacy of thermal ablation for the treatment of pulmonary carcinoid tumor: a propensity-matched analysis

References

• Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362–387. doi: 10.1016/j.jtho.2021.11.003.
   PubMed Web of Science ®Google Scholar
• Pelosi G, Sonzogni A, Harari S, et al. Classification of pulmonary neuroendocrine tumors: new insights. Transl Lung Cancer Res. 2017;6(5):513–529. doi: 10.21037/tlcr.2017.09.04.
   PubMed Web of Science ®Google Scholar
• Prinzi N, Rossi RE, Proto C, et al. Recent advances in the management of typical and atypical lung carcinoids. Clin Lung Cancer. 2021;22(3):161–169. doi: 10.1016/j.cllc.2020.12.004.
   PubMed Web of Science ®Google Scholar
• Baudin E, Caplin M, Garcia-Carbonero R, et al. Lung and thymic carcinoids: ESMO clinical practice guidelines for diagnosis, treatment and follow-up⋆. Ann Oncol. 2021;32(4):439–451. doi: 10.1016/j.annonc.2021.01.003.
   PubMed Web of Science ®Google Scholar
• Chiappetta M, Sperduti I, Ciavarella LP, et al. Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristics. Interact Cardiovasc Thorac Surg. 2020;31(3):315–323. doi: 10.1093/icvts/ivaa114.
   PubMed Web of Science ®Google Scholar
• Shah S, Gosain R, Groman A, et al. Incidence and survival outcomes in patients with lung neuroendocrine neoplasms in the United States. Cancers. 2021;13(8):1753. doi: 10.3390/cancers13081753.
   PubMed Web of Science ®Google Scholar
• Yang H, Xiao X, Mei T, et al. Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study. Aging Clin Exp Res. 2022;34(8):1925–1934. doi: 10.1007/s40520-022-02112-0.
   PubMed Web of Science ®Google Scholar
• Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–3072. doi: 10.1200/JCO.2007.15.4377.
   PubMed Web of Science ®Google Scholar
• Petursdottir A, Sigurdardottir J, Fridriksson BM, et al. Pulmonary carcinoid tumours: incidence, histology, and surgical outcome. A population-based study. Gen Thorac Cardiovasc Surg. 2020;68(5):523–529. doi: 10.1007/s11748-019-01261-w.
   PubMed Web of Science ®Google Scholar
• Gosain R, Groman A, Yendamuri SS, et al. Role of adjuvant chemotherapy in pulmonary carcinoids: an NCDB analysis. Anticancer Res. 2019;39(12):6835–6842. doi: 10.21873/anticanres.13900.
   PubMed Web of Science ®Google Scholar
• Rea F, Rizzardi G, Zuin A, et al. Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients. Eur J Cardiothorac Surg. 2007;31(2):186–191. doi: 10.1016/j.ejcts.2006.10.040.
   PubMed Web of Science ®Google Scholar
• Nussbaum DP, Speicher PJ, Gulack BC, et al. Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors. Ann Thorac Surg. 2015;99(2):428–434. doi: 10.1016/j.athoracsur.2014.08.030.
   PubMed Web of Science ®Google Scholar
• Yang H, Mei T. Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis. Interact Cardiovasc Thorac Surg. 2022;35:ivac125.
   PubMed Web of Science ®Google Scholar
• Ni Y, Huang G, Yang X, et al. Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results. Eur Radiol. 2022;32(8):5616–5622. doi: 10.1007/s00330-022-08615-8.
   PubMed Web of Science ®Google Scholar
• Yang WY, He Y, Hu Q, et al. Survival benefit of thermal ablation therapy for patients with stage II–III non-small cell lung cancer: a propensity-matched analysis. Front Oncol. 2022;12:984932. doi: 10.3389/fonc.2022.984932.
   PubMed Web of Science ®Google Scholar
• John JB, Anderson M, Dutton T, et al. Percutaneous microwave ablation of renal masses in a UK cohort. BJU Int. 2021;127(4):486–494. doi: 10.1111/bju.15224.
   PubMed Web of Science ®Google Scholar
• Lee J, Shin IS, Yoon WS, et al. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review. Radiother Oncol. 2020;145:63–70. doi: 10.1016/j.radonc.2019.12.004.
   PubMed Web of Science ®Google Scholar
• Xing M, Kokabi N, Zhang D, et al. Comparative effectiveness of thermal ablation, surgical resection, and active surveillance for T1a renal cell carcinoma: a surveillance, epidemiology, and end results (SEER)-medicare-linked population study. Radiology. 2018;288(1):81–90. doi: 10.1148/radiol.2018171407.
   PubMed Web of Science ®Google Scholar
• Yang H, Li M, Mei T. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis. Int J Hyperthermia. 2022;39(1):348–357. doi: 10.1080/02656736.2022.2038281.
   PubMed Web of Science ®Google Scholar
• Wang L, Xu J, Yu J, et al. Review of clinical tumor ablation advance in Asia. Int J Hyperthermia. 2021;38(1):1639–1649. doi: 10.1080/02656736.2021.1983037.
   PubMed Web of Science ®Google Scholar
• Chen S, Yang S, Xu S, et al. Comparison between radiofrequency ablation and sublobar resections for the therapy of stage I non-small cell lung cancer: a meta-analysis. PeerJ. 2020;8:e9228. doi: 10.7717/peerj.9228.
   PubMed Web of Science ®Google Scholar
• Iguchi T, Hiraki T, Matsui Y, et al. Survival outcomes of treatment with radiofrequency ablation, stereotactic body radiotherapy, or sublobar resection for patients with clinical stage I non-small-cell lung cancer: a single-center evaluation. J Vasc Interv Radiol. 2020;31(7):1044–1051. doi: 10.1016/j.jvir.2019.11.035.
   PubMed Web of Science ®Google Scholar
• Quirk MT, Lee S, Murali N, et al. Alternatives to surgery for early-stage non-small cell lung cancer: thermal ablation. Clin Chest Med. 2020;41(2):197–210. doi: 10.1016/j.ccm.2020.02.002.
   PubMed Web of Science ®Google Scholar
• Siperstein AE, Rogers SJ, Hansen PD, et al. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery. 1997;122(6):1147–1154. doi: 10.1016/s0039-6060(97)90221-x.
   PubMed Web of Science ®Google Scholar
• Corsello SM, Senes P, Iezzi R, et al. Cushing’s syndrome due to a bronchial ACTH-secreting carcinoid successfully treated with radiofrequency ablation (RFA). J Clin Endocrinol Metab. 2014;99(5):E862–5. doi: 10.1210/jc.2013-4359.
   PubMed Web of Science ®Google Scholar
• Baisi A, De Simone M, Raveglia F, et al. Thermal ablation in the treatment of lung cancer: present and future. Eur J Cardiothorac Surg. 2013;43(4):683–686. doi: 10.1093/ejcts/ezs558.
   PubMed Web of Science ®Google Scholar
• Song P, Zang R, Liu L, et al. Long-term outcomes and prognostic factors of patients with surgically treated pulmonary atypical carcinoid tumors: our institutional experience with 68 patients. J Thorac Dis. 2018;10(7):4204–4211. doi: 10.21037/jtd.2018.06.88.
   PubMed Web of Science ®Google Scholar
• Cusumano G, Fournel L, Strano S, et al. Surgical resection for pulmonary carcinoid: long-term results of multicentric study-the importance of pathological N status, more than we thought. Lung. 2017;195(6):789–798. doi: 10.1007/s00408-017-0056-8.
   PubMed Web of Science ®Google Scholar
• Brown LM, Cooke DT, Jett JR, et al. Extent of resection and lymph node assessment for clinical stage T1aN0M0 typical carcinoid tumors. Ann Thorac Surg. 2018;105(1):207–213. doi: 10.1016/j.athoracsur.2017.07.049.
   PubMed Web of Science ®Google Scholar
• Anderson KL, Jr, Mulvihill MS, Speicher PJ, et al. Adjuvant chemotherapy does not confer superior survival in patients with atypical carcinoid tumors. Ann Thorac Surg. 2017;104(4):1221–1230. doi: 10.1016/j.athoracsur.2017.05.011.
   PubMed Web of Science ®Google Scholar
• He Y, Zhao F, Han Q, et al. Prognostic nomogram for predicting long-term cancer-specific survival in patients with lung carcinoid tumors. BMC Cancer. 2021;21(1):141. doi: 10.1186/s12885-021-07832-6.
   PubMed Web of Science ®Google Scholar
• Bardasi C, Benatti S, Luppi G, et al. Carcinoid crisis: a misunderstood and unrecognized oncological emergency. Cancers. 2022;14(3):662. doi: 10.3390/cancers14030662.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Adikrisna R, Shimada K, et al. Multimodal therapy improved carcinoid syndrome secondary to liver metastases of an atypical lung carcinoid tumor: a case report. Nihon Shokakibyo Gakkai Zasshi. 2020;117:635–645.
   PubMedGoogle Scholar
• Papadogias D, Makras P, Kossivakis K, et al. Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challenge. Eur J Gastroenterol Hepatol. 2007;19(12):1154–1159. doi: 10.1097/MEG.0b013e3282294d88.
   PubMed Web of Science ®Google Scholar